FDA Gives Accelerated Approval to New ALS Treatment
Tofersen, an injection treatment for a rare form of ALS, has been approved under the accelerated approval pathway.
FDA Gives Accelerated Approval to New ALS Treatment Read More »
Dr. Weisman participates in FDA Advisory Committee
The committee convened to discuss tofersen, an experimental injection for treatment of ALS.
Dr. Weisman participates in FDA Advisory Committee Read More »
ANA administers first lecanemab infusion in PA
Leqembi significantly reduces progression of memory loss in those with Alzheimer’s disease by about 30%.
ANA administers first lecanemab infusion in PA Read More »
Dr. Weisman Quoted in Philadelphia Inquirer Article on Lecanemab
Blood tests for Alzheimer’s biomarkers will be a powerful tool in determining who will benefit from a drug.
Dr. Weisman Quoted in Philadelphia Inquirer Article on Lecanemab Read More »
Lecanemab Reduces Cognitive Decline in Alzheimer’s
We hope to serve our community with infusions to help this unmet medical need while continuing to work on the next generation of Alzheimer treatments.
Lecanemab Reduces Cognitive Decline in Alzheimer’s Read More »
Dr. Weisman Quoted in NY Times Article on Aducanumab
Medicare should require safety monitoring and medical expertise in the use of aducanumab.
Dr. Weisman Quoted in NY Times Article on Aducanumab Read More »
Aducanumab: Neither Far Nor Deep
While we might not have clear progress, we do have an advance.
Aducanumab: Neither Far Nor Deep Read More »
Aducanumab Update
While various opinions are circulating, and the benefits of this drug are unclear, ANA will continue to monitor the situation and provide updates as information becomes available.
How to Get a Good Night’s Sleep
Establishing good sleep habits is the first step to improving your sleep quality.
How to Get a Good Night’s Sleep Read More »
